125
Views
11
CrossRef citations to date
0
Altmetric
Review

Management of moderate to severe chronic low back pain with buprenorphine buccal film using novel bioerodible mucoadhesive technology

, , , &
Pages 909-916 | Published online: 31 Oct 2016

Figures & data

Figure 1 A literature search was conducted using PubMed, Cochrane, Embase, and Scopus databases, resulting in nine articles relevant to the objective.

Figure 1 A literature search was conducted using PubMed, Cochrane, Embase, and Scopus databases, resulting in nine articles relevant to the objective.

Table 1 Pharmacokinetic parameters across various buprenorphine products indicated for pain control

Figure 2 Significantly more patients achieved ≥30% pain reduction in the BBUP (63%) vs placebo (47%) groups, P=0.0012.

Note: Significance is indicated by the asterisk. The black bars indicate the proportion of patients who achieved at ≥30% and ≥50% pain intensity with BBUP. The white bars indicate the placebo rates. Data from Rauck et al.Citation52
Abbreviation: BBUP, buccal buprenorphine.
Figure 2 Significantly more patients achieved ≥30% pain reduction in the BBUP (63%) vs placebo (47%) groups, P=0.0012.